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Abstract
AIM: To evaluate the prevalence of John Cunningham 
virus (JC virus) in a small cohort of patients with colon 
cancer and to assess its presence in hepatic metastasis.
METHODS: Nineteen consecutive patients with histo-
logically diagnosed colon cancer were included in our 
study, together with ten subjects affected by histo-
logically and serologically diagnosed hepatitis C virus 
infection. In the patients included in the colon cancer 
group, JC virus was searched for in the surgical speci-
men; in the control group, JC virus was searched for in 
the hepatic biopsy. The difference in the prevalence of 
JC virus in the hepatic biopsy between the two groups 
was assessed through the χ 2 test.
RESULTS: Four out of 19 patients with colon cancer 
had a positive polymerase chain reaction (PCR) test 
for JC virus, and four had liver metastasis. Among the 
patients with liver metastasis, three out of four had a 
positive PCR test for JC virus in the surgical specimen 
and in the liver biopsy; the only patient with liver me-
tastasis with a negative test for JC virus also presented 
a negative test for JC virus in the surgical specimen. In 
the control group of patients with hepatitis C infection, 
none of the ten patients presented JC virus infection 
in the hepatic biopsy. The difference between the two 
groups regarding JC virus infection was statistically 
significant (χ 2 = 9.55, P  = 0.002).
CONCLUSION: JC virus may play a broader role than 
previously thought, and may be mechanistically in-
volved in the late stages of these tumors.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
Key words: John Cunningham virus; Colon cancer; Me-
tastasis
Core tip: This is the first case-control study, to our 
knowledge, assessing, although with a small sample 
size, the potential metastatic spread of John Cunning-
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INTRODUCTION
Colorectal cancer (CRC) is the third most frequent ma-
lignancy, and constitutes the second leading cause of  
cancer mortality among both men and women in the 
United States[1]. Mortality in CRC is usually caused by 
metastatic disease. Even if  increasing efforts to the diag-
nosis of  CRC at an early stage with screening programs, 
more than 25% of  patients are still diagnosed with meta-
static disease, and a further 25% develop metastases. 
Up to now, the molecular mechanisms underlying the 
development of  metastasis are not fully understood[2]. 
Actually, infectious diseases are acquiring relevance be-
cause they are thought as leading pathogenic elements 
in human cancer: in fact all about twenty percent of  
human cancers are associated with infectious agents, 
particularly in the gastrointestinal tract[3], but this is not a 
mainstream oncologic research area. It has been thought 
that the development of  several types of  human cancers 
could be triggered by exposure to different infectious 
agents, such as human papilloma virus (HPV) infection 
associated with cervical carcinoma[4], hepatitis B virus 
associated with liver carcinoma[5], Epstein-Barr virus as-
sociated with Burkitt lymphomas[6], HTVL-1 associated 
with Adult T-cell Leukemia/Lymphoma[7], or Helico-
bacter pylori associated with gastric carcinoma[8]; more 
recently a human retrovirus, XMRV, has been associated 
with sporadic prostate cancer[9-11]. In addition, an as-
sociation has been reported between the development 
of  lower gastrointestinal tract neoplasias and infectious 
agents[8], e.g., between CRC and John Cunningham virus 
(JC virus) infection.
JC virus, a member of  the polyomaviridae family, 
ubiquitously infects humans, 70% to 80% of  the adult 
population having JC virus-specific antibodies[12,13]. Sev-
eral studies demonstrated that JC virus infection takes 
place during early childhood and remains subclinical. 
After primary infection, JC virus can be found in the 
kidneys, B lymphocytes, and gut mucosa.
However, under conditions of  severe immunosup-
pression, the virus could become reactivated and induce 
the fatal demyelinating disease progressive multifocal 
leukoencephalopathy (PML)[14]. In addition, there is an 
increasing evidence that JC virus may be associated with 
several human neoplasias. In fact, JC virus genomic 
sequences and oncogenic T-antigen (T-Ag) expression 
have been reported in a variety of  human malignancies, 
including brain tumors[15,16] CRC[17-20], gastric cancer[21], 
and esophageal cancer[22].
JC virus has been reported to be associated with CRC 
and could contribute to the cancer phenotype by several 
mechanisms. Among JC virus proteins, two in particular, 
large T-antigen and agnoprotein, could interfere with cell 
cycle control and genomic instability mechanisms, but 
further viral proteins could also contribute to cell trans-
formation. Some viral DNA sequences are found in car-
cinoma lesions, but less frequently in adenomas, and not 
in the normal tissue. These findings suggest that viral 
DNA integration in the host cell genome might result in 
chromosomal damage and malignant transformation[23]. 
However, to date its role in provoking metastasis has 
not been demonstrated, though it has been hypothesized 
that JC virus T-Ag could mediate metastasis in CRC cells 
through increased migration and invasion[24].
The aim of  this study is to evaluate the prevalence of  
JC virus in a small cohort of  patient with colon cancer 
and to assess its presence in hepatic metastasis, compar-
ing it with a cohort of  patients with liver disease but 
without colon cancer.
MATERIALS AND METHODS
Study population
Nineteen consecutive patients (47.4% male, 52.6% fe-
male) with histologically diagnosed colon cancer, fol-
lowed between January 2012 and October 2012 at our 
hospital, were included in the study, together with ten 
subjects, employed as a control group of  individuals in 
the same geographic areas, affected by histologically and 
serologically diagnosed hepatitis C virus infection. This 
cohort of  control subject was chosen to assess the preva-
lence of  JC virus in the livers of  patients without known 
primary colorectal cancer.
Among patients from the colon cancer group, JC virus 
was searched for in the surgical specimen (primary colon 
cancer tissue and liver metastasis tissue); in the control 
group, JC virus was searched for in the hepatic biopsy. 
Liver biopsies were all standard percutaneous samples, 
and the threshold of  adequacy for histological assessment 
was the presence of  more than five portal tracts.
The difference in the prevalence of  JC virus in the he-
patic biopsy between the two groups was assessed through 
the χ 2 test.
DNA extraction
Paraffin-embedded tissues were sectioned at 10 microns 
and five sections were cut with a standard microtome 
and transferred into a 1.5 mL microtube.
To prevent cross-contamination between the sam-
ples, the microtome blade was washed with xylene and 
ethanol after sectioning of  each block.
Genomic DNA was extracted from paraffin embed-
ded tissue section using the ZR Genomic DNA-Tissue 
Miniprep (Zymo Research, United States), according to 
the manufacturer’s recommendations.
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Table 1  Clinical and pathological features of the patients with colorectal cancer
Extreme caution was taken to perform all prepara-
tory polymerase chain reaction (PCR) steps, including 
DNA extraction in a separate room isolated from any 
post-PCR samples to prevent contamination.
All the DNA samples were amplified using beta-
globin primers (fragment of  175 bp) to confirm their 
integrity.
Nested PCR for the JC virus genoma
For the detection of  JC virus gene sequences, poly-
merase chain reaction amplifications were performed us-
ing gene-specific primers for T-antigen.
For JC virus T-antigen, T1 and T2 (nucleotides 
3049-3069 of  the Mad-1 strain, 5’ TGGCCTGTA-
AAGTTCTAGGCA 3’ and 3229-3207, 5’ GCAGAGT-
CAAGGGATTTACCTTC 3’ respectively) which amplify 
sequences in the NH2-terminal region of  the JC virus 
T-antigen, were used for the first PCR, whereas T1 and T3 
(nucleotides 3193-3171, 5’ AGCAACCTTGATTGCTTA-
AGAGA 3’) were used for the second PCR (110 bp)[25].
PCR reaction mixture contained 0.5 U Taq poly-
merase, 1 × PCR Buffer (50 mmol/L KCl and 10 nmol/L 
MgCl2, 10 pmol of  each dNTPs, 1.5 mmol/L MgCl2, 10 
pmol of  each primers and 100-200 ng of  extracted DNA.
PCR conditions were denatured at 95 ℃ for 10 min, 
followed by 30 cycles of  denaturation at 95 ℃ for 15 s , 
annealing at 55 ℃ for 30 s and extension at 72 ℃ for 30 
s followed by 7 min final extension at 72 ℃.
Nested PCR was carried out as the first PCR cycles, 
using 1% (volume) of  the first PCR product with inter-
nal primers.
The PCR amplification products were run on 2% 
agarose gel and stained with ethidium bromide and visu-
alized under ultraviolet light.
RESULTS
Clinical and demographical data of  the study population 
are summarized in Table 1.
Four out of  19 patients (21.05%) with colon cancer 
had a positive PCR test for JC virus, and four (21.05%) 
had liver metastasis. Among the four patients with liver 
metastasis, three out of  4 (75%) had a positive PCR test 
for JC virus both in the surgical specimen and in the 
liver specimen; the only patient with liver metastasis with 
a negative test for JC virus also presented a negative test 
for JC virus in the primary tumor.
In the control group of  patients with hepatitis C in-
fection, none of  the ten patients (0%) presented JC virus 
infection in the hepatic biopsy.
The difference between the two groups regarding JC 
virus infection was statistically significant (χ 2 = 9.55, P = 
0.002).
DISCUSSION
JC virus DNA sequences and proteins have been found 
in a wide range of  human neoplasias of  glial and non-
glial origin, as gliomas, ependymomas and medulloblas-
tomas, as well as in several non-neural clinical specimens 
of  gastrointestinal tumors, such as CRC[8], suggesting 
that they could infect a broad range of  cell types. How-
ever, the role of  JC virus in such neoplasias is poorly 
understood.
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Age (median, range), yr 70 (59-87)
Location of the colorectal cancer (n) Caecum and ascending colon: 12/19
Transverse colon: 1/19
Descending colon: 2/19
Sigma 3/19
Rectum 1/19
Sex (Male:Female)   7:12
Grading G1: 1/19
  G2: 12/19
G3: 6/19
Staging according to Dukes’ Classification (n) A: 0/19
B1: 0/19
B2: 2/19
C1: 3/19
  C2: 10/19
D: 4/19
Mucinous component (n)   5:19
Signet ring component (n)   5:19
Presence of tumor infiltrating lymphocytes (n) 12:19
Perineural invasion (n) 10:19
Microvascular invasion (n) 10:19
Lymphangiosis (n)   1:19
JC virus positivity in the colonic specimen (n)   4:19
Liver metastasis (n)   4:19
JC virus positivity in the hepatic specimen (n)   3:19
JC virus: John Cunningham virus.
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Even if  several studies have evaluated the role of  the 
presence of  JC virus DNA in colonic tissue using PCR, 
more recently Burnett-Hartman and coworkers reviewed 
five studies examining colorectal neoplastic tissue detect-
ing JC virus DNA in colorectal neoplasias at varying 
frequencies, finding from 26% to 89% of  carcinomas 
positive for JC virus.
A very important challenge is to establish whether 
the presence of  JC virus presents any difference between 
tumors of  different grades and its normal surrounding 
mucosa. Few studies have been performed in this context.
Two studies evaluated colorectal adenomatous tis-
sue from separate patients with adenomas and normal 
colorectal tissues from controls. The first study reported 
a JC virus infection in 61% of  cancerous tissue, 60% of  
adenomatous tissue and 30% of  normal tissue samples 
from controls, showing a OR = 6.2 (95%CI: 2.4-16.6) 
comparing neoplastic tissue to normal tissue. This study 
showed that JC virus viral copy numbers were statistical-
ly significantly higher in neoplastic colorectal tissue with 
regard to normal colorectal tissue[26]. The second study 
presented lower rates of  detection for JC virus, finding 
26% of  cancerous colorectal tissue, 5% of  adenomas 
and 0% of  normal tissue positive for JC virus[27].
Furthermore, in the study performed by Link and co-
workers[24], some phenotypic changes were demonstrated 
that were associated with marked alterations in the ex-
pression of  a large number of  genes of  JC virus. These 
results are in line with a previous study by Nerurkar and 
colleagues in which the authors analyzed gene expression 
alterations following transfection of  a full-length JC virus 
plasmid into glial cells[28]. Indeed, the study of  Link and 
coworkers suggests a novel role for JC virus T-Ag in hu-
man CRC. The authors demonstrated that transfection 
of  JC virus early transcripts into cancer cells could in-
creases migration and invasion through up-regulation of  
metastasis-associated genes[24].
Our study presents some limitations, like the retro-
spective design, the small number of  patients with liver 
metastasis and the absence of  detection of  JC virus in the 
normal mucosa surrounding the colorectal cancer, as well 
as the absence of  mention of  the level of  viral expres-
sion in the analyzed tissue. However, the primary aim of  
our study was simply to assess the presence of  JC virus 
in the hepatic metastasis of  colorectal cancer, comparing 
it with a cohort of  patients with liver disease but without 
colon cancer. Furthermore, our points of  strength are the 
presence of  a control group and the finding of  a preva-
lence of  JC virus, in colon cancer, which has largely been 
overlooked in the scientific literature, with the finding of  
the scientific literature, with the exception of  the study 
performed by Link and co-workers[24].
Based on this data, we propose that JC virus T-Ag may 
play a broader role than previously thought, and may be 
mechanistically involved in the late stages of  these tumors.
Forthcomings prospective case-control studies, with a 
larger number of  patients in both the arms and targeted 
to evaluate the difference in the level of  expression of  
JC virus in the primary tumoral colonic tissue and in the 
normal surrounding colonic mucosa, as well as to study 
migration and invasion, could clarify the true prevalence 
of  JC virus in colon cancer and in liver metastasis, mak-
ing it possible to find a true “mechanical” role of  JC 
virus in the late stages of  CRC.
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